Global and Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2026

Global and Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Insights, Forecast to 2026

Table of Contents
1 Study Coverage
1.1 Over the Counter (OTC) Drugs & Dietary Supplements Product Introduction
1.2 Market Segments
1.3 Key Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type
1.4.2 Analgesic & pain relievers
1.4.3 Dermatological products
1.4.4 Cough, cold, and flu products
1.4.5 Vitamin supplements
1.4.6 Mineral Supplements
1.4.7 Ophthalmic Products
1.5 Market by Application
1.5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application
1.5.2 Pharmacies
1.5.3 Grocery Stores
1.5.4 Vitamin
1.5.5 Health Food Stores
1.5.6 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size, Estimates and Forecasts
2.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue 2015-2026
2.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales 2015-2026
2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Over the Counter (OTC) Drugs & Dietary Supplements Historical Market Size by Region (2015-2020)
2.3.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Region (2021-2026)
2.4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Region (2021-2026)
3 Global Over the Counter (OTC) Drugs & Dietary Supplements Competitor Landscape by Players
3.1 Global Top Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers
3.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020)
3.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Manufacturers (2015-2020)
3.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue
3.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020)
3.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Over the Counter (OTC) Drugs & Dietary Supplements Revenue in 2019
3.2.5 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price by Manufacturers
3.4 Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturing Base Distribution, Product Types
3.4.1 Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
3.4.3 Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Type (2015-2020)
4.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020)
4.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020)
4.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Type (2021-2026)
4.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
4.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
4.2.3 Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Application (2015-2020)
5.1.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020)
5.1.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020)
5.1.3 Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
5.2 Over the Counter (OTC) Drugs & Dietary Supplements Market Size Forecast by Application (2021-2026)
5.2.1 Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
5.2.2 Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
5.2.3 Global Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
6.1.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales YoY Growth 2015-2026
6.1.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue YoY Growth 2015-2026
6.1.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Share in Global Market 2015-2026
6.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Players (International and Local Players)
6.2.1 Japan Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Sales (2015-2020)
6.2.2 Japan Top Over the Counter (OTC) Drugs & Dietary Supplements Players by Revenue (2015-2020)
6.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Type (2015-2020)
6.3.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Type (2015-2020)
6.3.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Type (2015-2020)
6.3.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price by Type (2015-2020)
6.4 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Type (2021-2026)
6.4.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Type (2021-2026)
6.4.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Type (2021-2026)
6.5 Japan Over the Counter (OTC) Drugs & Dietary Supplements Historic Market Review by Application (2015-2020)
6.5.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Application (2015-2020)
6.5.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Application (2015-2020)
6.5.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price by Application (2015-2020)
6.6 Japan Over the Counter (OTC) Drugs & Dietary Supplements Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Application (2021-2026)
6.6.2 Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Forecast by Application (2021-2026)
6.6.3 Japan Over the Counter (OTC) Drugs & Dietary Supplements Price Forecast by Application (2021-2026)
7 North America
7.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
7.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
7.2.1 North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020)
7.2.2 North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
8.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
8.2.1 Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
8.2.2 Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
9.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
9.2.1 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020)
9.2.2 Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
10.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
10.2.1 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
10.2.2 Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Market Facts & Figures by Country
11.2.1 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country
11.2.2 Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer Inc.
12.1.1 Pfizer Inc. Corporation Information
12.1.2 Pfizer Inc. Description and Business Overview
12.1.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.1.5 Pfizer Inc. Recent Development
12.2 Novartis International AG
12.2.1 Novartis International AG Corporation Information
12.2.2 Novartis International AG Description and Business Overview
12.2.3 Novartis International AG Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.2.5 Novartis International AG Recent Development
12.3 Roche Holding AG
12.3.1 Roche Holding AG Corporation Information
12.3.2 Roche Holding AG Description and Business Overview
12.3.3 Roche Holding AG Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.3.5 Roche Holding AG Recent Development
12.4 Merck & Co., Inc.
12.4.1 Merck & Co., Inc. Corporation Information
12.4.2 Merck & Co., Inc. Description and Business Overview
12.4.3 Merck & Co., Inc. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.4.5 Merck & Co., Inc. Recent Development
12.5 Sanofi S.A
12.5.1 Sanofi S.A Corporation Information
12.5.2 Sanofi S.A Description and Business Overview
12.5.3 Sanofi S.A Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.5.5 Sanofi S.A Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Gilead Sciences
12.7.1 Gilead Sciences Corporation Information
12.7.2 Gilead Sciences Description and Business Overview
12.7.3 Gilead Sciences Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.7.5 Gilead Sciences Recent Development
12.8 GlaxoSmithKline plc.
12.8.1 GlaxoSmithKline plc. Corporation Information
12.8.2 GlaxoSmithKline plc. Description and Business Overview
12.8.3 GlaxoSmithKline plc. Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.8.5 GlaxoSmithKline plc. Recent Development
12.9 Bayer Healthcare AG
12.9.1 Bayer Healthcare AG Corporation Information
12.9.2 Bayer Healthcare AG Description and Business Overview
12.9.3 Bayer Healthcare AG Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.9.5 Bayer Healthcare AG Recent Development
12.10 AstraZeneca plc.
12.10.1 AstraZeneca plc. Corporation Information
12.10.2 AstraZeneca plc. Description and Business Overview
12.10.3 AstraZeneca plc. Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.10.5 AstraZeneca plc. Recent Development
12.11 Pfizer Inc.
12.11.1 Pfizer Inc. Corporation Information
12.11.2 Pfizer Inc. Description and Business Overview
12.11.3 Pfizer Inc. Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Products Offered
12.11.5 Pfizer Inc. Recent Development
12.12 Alcon Inc.
12.12.1 Alcon Inc. Corporation Information
12.12.2 Alcon Inc. Description and Business Overview
12.12.3 Alcon Inc. Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Alcon Inc. Products Offered
12.12.5 Alcon Inc. Recent Development
12.13 Alfresa Pharma Corporation
12.13.1 Alfresa Pharma Corporation Corporation Information
12.13.2 Alfresa Pharma Corporation Description and Business Overview
12.13.3 Alfresa Pharma Corporation Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Alfresa Pharma Corporation Products Offered
12.13.5 Alfresa Pharma Corporation Recent Development
12.14 Alkalon A/S
12.14.1 Alkalon A/S Corporation Information
12.14.2 Alkalon A/S Description and Business Overview
12.14.3 Alkalon A/S Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Alkalon A/S Products Offered
12.14.5 Alkalon A/S Recent Development
12.15 Alliance Healthcare
12.15.1 Alliance Healthcare Corporation Information
12.15.2 Alliance Healthcare Description and Business Overview
12.15.3 Alliance Healthcare Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Alliance Healthcare Products Offered
12.15.5 Alliance Healthcare Recent Development
12.16 Allergan, Plc.
12.16.1 Allergan, Plc. Corporation Information
12.16.2 Allergan, Plc. Description and Business Overview
12.16.3 Allergan, Plc. Sales, Revenue and Gross Margin (2015-2020)
12.16.4 Allergan, Plc. Products Offered
12.16.5 Allergan, Plc. Recent Development
12.17 Reckitt Benckiser Plc.
12.17.1 Reckitt Benckiser Plc. Corporation Information
12.17.2 Reckitt Benckiser Plc. Description and Business Overview
12.17.3 Reckitt Benckiser Plc. Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Reckitt Benckiser Plc. Products Offered
12.17.5 Reckitt Benckiser Plc. Recent Development
12.18 Bausch & Lomb
12.18.1 Bausch & Lomb Corporation Information
12.18.2 Bausch & Lomb Description and Business Overview
12.18.3 Bausch & Lomb Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Bausch & Lomb Products Offered
12.18.5 Bausch & Lomb Recent Development
12.19 AbbVie Inc.
12.19.1 AbbVie Inc. Corporation Information
12.19.2 AbbVie Inc. Description and Business Overview
12.19.3 AbbVie Inc. Sales, Revenue and Gross Margin (2015-2020)
12.19.4 AbbVie Inc. Products Offered
12.19.5 AbbVie Inc. Recent Development
12.20 The Colgate-Palmolive Company
12.20.1 The Colgate-Palmolive Company Corporation Information
12.20.2 The Colgate-Palmolive Company Description and Business Overview
12.20.3 The Colgate-Palmolive Company Sales, Revenue and Gross Margin (2015-2020)
12.20.4 The Colgate-Palmolive Company Products Offered
12.20.5 The Colgate-Palmolive Company Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Over the Counter (OTC) Drugs & Dietary Supplements Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Over the Counter (OTC) Drugs & Dietary Supplements Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Over the Counter (OTC) Drugs & Dietary Supplements Market Segments
Table 2. Ranking of Global Top Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Analgesic & pain relievers
Table 5. Major Manufacturers of Dermatological products
Table 6. Major Manufacturers of Cough, cold, and flu products
Table 7. Major Manufacturers of Vitamin supplements
Table 8. Major Manufacturers of Mineral Supplements
Table 9. Major Manufacturers of Ophthalmic Products
Table 10. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size Growth Rate by Application 2020-2026 (K MT)
Table 11. Global Over the Counter (OTC) Drugs & Dietary Supplements Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 12. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Regions 2015-2020 (K MT)
Table 13. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Regions (2015-2020)
Table 14. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Regions 2015-2020 (US$ Million)
Table 15. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Forecast by Region (2021-2026) (K MT)
Table 16. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Manufacturers (2015-2020) (K MT)
Table 17. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Manufacturers (2015-2020)
Table 18. Global Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 19. Global Over the Counter (OTC) Drugs & Dietary Supplements by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Over the Counter (OTC) Drugs & Dietary Supplements as of 2019)
Table 20. Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Manufacturers (2015-2020) (US$ Million)
Table 21. Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Manufacturers (2015-2020)
Table 22. Key Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Price (2015-2020) (USD/MT)
Table 23. Over the Counter (OTC) Drugs & Dietary Supplements Manufacturers Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Over the Counter (OTC) Drugs & Dietary Supplements Product Type
Table 25. Date of International Manufacturers Enter into Over the Counter (OTC) Drugs & Dietary Supplements Market
Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 27. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Type (2015-2020) (K MT)
Table 28. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 29. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Type (2015-2020) (US$ Million)
Table 30. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2015-2020)
Table 31. Over the Counter (OTC) Drugs & Dietary Supplements Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 32. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2021-2026)
Table 33. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales by Application (2015-2020) (K MT)
Table 34. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 35. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2021-2026)
Table 36. Global Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share Forecast by Application (2021-2026)
Table 37. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Application (2015-2020) (US$ Million)
Table 38. Global Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share Forecast by Application (2021-2026)
Table 39. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) of Key Companies (2015-2020)
Table 40. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Company (2015-2020)
Table 41. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) by Company (2015-2020)
Table 42. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2015-2020)
Table 43. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2015-2020)
Table 44. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Type (2015-2020)
Table 45. Japan Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Type (2015-2020)
Table 46. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Type (2021-2026)
Table 47. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Type (2021-2026)
Table 48. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Type (2021-2026)
Table 49. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Type (2021-2026)
Table 50. Japan Over the Counter (OTC) Drugs & Dietary Supplements Price (K MT) by Type (2021-2026)
Table 51. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2015-2020)
Table 52. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2015-2020)
Table 53. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Application (2015-2020)
Table 54. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT) by Application (2021-2026)
Table 55. Japan Over the Counter (OTC) Drugs & Dietary Supplements Sales Share by Application (2021-2026)
Table 56. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue (US$ Million) Market Share by Application (2021-2026)
Table 57. Japan Over the Counter (OTC) Drugs & Dietary Supplements Revenue Share by Application (2021-2026)
Table 58. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 59. North America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 60. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 61. North America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 62. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 63. Europe Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 64. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 65. Europe Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 66. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales by Region (2015-2020) (K MT)
Table 67. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Region (2015-2020)
Table 68. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Region (2015-2020) (US$ Million)
Table 69. Asia Pacific Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Region (2015-2020)
Table 70. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 71. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 72. Latin Americaa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 73. Latin America Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 74. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales by Country (2015-2020) (K MT)
Table 75. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Sales Market Share by Country (2015-2020)
Table 76. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue by Country (2015-2020) (US$ Million)
Table 77. Middle East and Africa Over the Counter (OTC) Drugs & Dietary Supplements Revenue Market Share by Country (2015-2020)
Table 78. Pfizer Inc. Corporation Information
Table 79. Pfizer Inc. Description and Business Overview
Table 80. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 81. Pfizer Inc. Over the Counter (OTC) Drugs & Dietary Supplements Product
Table 82. Pfizer Inc. Recent Development
Table 83. Novartis International AG Corporation Information
Table 84. Novartis International AG Description and Business Overview
Table 85. Novartis International AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 86. Novartis International AG Product
Table 87. Novartis International AG Recent Development
Table 88. Roche Holding AG Corporation Information
Table 89. Roche Holding AG Description and Business Overview
Table 90. Roche Holding AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 91. Roche Holding AG Product
Table 92. Roche Holding AG Recent Development
Table 93. Merck & Co., Inc. Corporation Information
Table 94. Merck & Co., Inc. Description and Business Overview
Table 95. Merck & Co., Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 96. Merck & Co., Inc. Product
Table 97. Merck & Co., Inc. Recent Development
Table 98. Sanofi S.A Corporation Information
Table 99. Sanofi S.A Description and Business Overview
Table 100. Sanofi S.A Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 101. Sanofi S.A Product
Table 102. Sanofi S.A Recent Development
Table 103. Johnson & Johnson Corporation Information
Table 104. Johnson & Johnson Description and Business Overview
Table 105. Johnson & Johnson Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 106. Johnson & Johnson Product
Table 107. Johnson & Johnson Recent Development
Table 108. Gilead Sciences Corporation Information
Table 109. Gilead Sciences Description and Business Overview
Table 110. Gilead Sciences Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 111. Gilead Sciences Product
Table 112. Gilead Sciences Recent Development
Table 113. GlaxoSmithKline plc. Corporation Information
Table 114. GlaxoSmithKline plc. Description and Business Overview
Table 115. GlaxoSmithKline plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 116. GlaxoSmithKline plc. Product
Table 117. GlaxoSmithKline plc. Recent Development
Table 118. Bayer Healthcare AG Corporation Information
Table 119. Bayer Healthcare AG Description and Business Overview
Table 120. Bayer Healthcare AG Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 121. Bayer Healthcare AG Product
Table 122. Bayer Healthcare AG Recent Development
Table 123. AstraZeneca plc. Corporation Information
Table 124. AstraZeneca plc. Description and Business Overview
Table 125. AstraZeneca plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 126. AstraZeneca plc. Product
Table 127. AstraZeneca plc. Recent Development
Table 128. Alacer Corp. Corporation Information
Table 129. Alacer Corp. Description and Business Overview
Table 130. Alacer Corp. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 131. Alacer Corp. Product
Table 132. Alacer Corp. Recent Development
Table 133. Alcon Inc. Corporation Information
Table 134. Alcon Inc. Description and Business Overview
Table 135. Alcon Inc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 136. Alcon Inc. Product
Table 137. Alcon Inc. Recent Development
Table 138. Alfresa Pharma Corporation Corporation Information
Table 139. Alfresa Pharma Corporation Description and Business Overview
Table 140. Alfresa Pharma Corporation Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 141. Alfresa Pharma Corporation Product
Table 142. Alfresa Pharma Corporation Recent Development
Table 143. Alkalon A/S Corporation Information
Table 144. Alkalon A/S Description and Business Overview
Table 145. Alkalon A/S Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 146. Alkalon A/S Product
Table 147. Alkalon A/S Recent Development
Table 148. Alliance Healthcare Corporation Information
Table 149. Alliance Healthcare Description and Business Overview
Table 150. Alliance Healthcare Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 151. Alliance Healthcare Product
Table 152. Alliance Healthcare Recent Development
Table 153. Allergan, Plc. Corporation Information
Table 154. Allergan, Plc. Description and Business Overview
Table 155. Allergan, Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 156. Allergan, Plc. Product
Table 157. Allergan, Plc. Recent Development
Table 158. Reckitt Benckiser Plc. Corporation Information
Table 159. Reckitt Benckiser Plc. Description and Business Overview
Table 160. Reckitt Benckiser Plc. Over the Counter (OTC) Drugs & Dietary Supplements Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 161. Reckitt Benckiser Plc. Product
Table 162. Reckitt Benckiser Plc. Recent Development
Table 163. Bausch & Lomb Corporation Information
Table 164. Bausch & Lomb Descripti

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs